semaglutide affect blood pressure GLP-1s and Pressure​: Benefits, Risks, and More Data confirms that semaglutide lowers

Limonte CP, et al

CJC-1295 enhances GH pulse amplitude, while Ipamorelin increases pulse frequency, enabling investigation of synergistic GH/IGF-1 responses

The SURPASS-2 trial compared tirzepatide with semaglutide 1 mg weekly, showing that tirzepatide achieved HbA1c reductions of 2.01%, 2.24%, and 2.30% at doses of 5 mg, 10 mg, and 15 mg respectively, versus 1.86% with semaglutide

Findings thus far have been translated into recommendations in clinical guidelines by the American College of Cardiology, American Heart Association, European Society of Cardiology, and American Diabetes Association

Update on FDAs ongoing evaluation of reports of suicidal thoughts-or-actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity

By the first three quarters of 2024, tirzepatide's cumulative sales had reached $11 billion